1.Vallet S, Raje N, Ishitsuka K, Hideshima T, Podar K, Chhetri S, Pozzi S, Breitkreutz I, Kiziltepe T, Yasui H et al.. (2007) MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts.. Blood, 110 (10):(3744-52). [PMID:17715391]
2.Vergunst CE, Gerlag DM, von Moltke L, Karol M, Wyant T, Chi X, Matzkin E, Leach T, Tak PP. (2009) MLN3897 plus methotrexate in patients with rheumatoid arthritis: safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study.. Arthritis Rheum, 60 (12):(3572-81). [PMID:19950299]
3.Pusalkar S, Plesescu M, Milton M, Balani SK, Chowdhury S, Prakash S. (2016) Metabolism, Excretion and Pharmacokinetics of MLN3897, a CCR1 Antagonist, in Humans.. Drug Metab Lett, 10 (1):(22-37). [PMID:26031460]
Solution Calculators
Molarity Calculator
Determine the necessary mass, volume, or concentration for preparing a solution.
Dilution Calculator
Determine the dilution needed to prepare a stock solution.
